You are here: Industry Insights > hypertension

News List

CVD Risk Up in Later Life for Young Adults With High LDL or Hypertension drugs
July 17, 2019
CVD Risk Up in Later Life for Young Adults With High LDL or Hypertension.
Risk for Arterial Hypertension Up With Air Pollutant Exposure drugs
July 16, 2019
Risk for Arterial Hypertension Up With Air Pollutant Exposure.
Uncontrolled Diabetes, Hypertension Rates High in CKD Patients drugs
July 12, 2019
Uncontrolled Diabetes, Hypertension Rates High in CKD Patients.
J&J announce first-of-its-kind portopulmonary hypertension study results pharmatimes
June 11, 2019
Johnson & Johnson's Opsumit (macitentan) has shown significant improvement in pulmonary vascular resistance (PVR) in patients with portopulmonary hypertension (PoPH) after 24 weeks, in data published in The Lancet Respiratory Medicine.
CMFRI develops nutraceutical product to combat hypertension Kochi expressbpd
May 29, 2019
The institute has already developed and commercialised natural products for diseases such as diabetes, arthritis, cholesterol and hypothyroid
Daiichi Sankyo receives Japanese marketing approval for two drugs pharmaceutical-technology
January 10, 2019
Daiichi Sankyo has obtained marketing approval in Japan for its minnebro and tarlige tablets to treat hypertension and peripheral neuropathic pain (PNP) respectively.....
Amazon sells exclusive diabetes and hypertension devices pharmaphorum
December 18, 2018
Amazon has launched an exclusive range of medical devices to help people manage their diabetes and hypertension at home.The Choice devices, produced by the healthcare consultancy....
Sandoz Issues Recall of Losartan Potassium, Hydrochlorothiazide americanpharmaceuticalreview
November 10, 2018
Sandoz is voluntarily recalling one lot of Losartan Potassium Hydrochlorothiazide Tablets, USP 100mg/25mg to the consumer level. This product is being recalled due to the trace amount of an impurity, N-nitrosodiethylamine (NDEA) contained in the API Losar
Sandoz Issues Recall of Losartan Potassium, Hydrochlorothiazide americanpharmaceuticalreview
November 10, 2018
Sandoz is voluntarily recalling one lot of Losartan Potassium Hydrochlorothiazide Tablets, USP 100mg/25mg to the consumer level. This product is being recalled due to the trace amount of an impurity, N-nitrosodiethylamine (NDEA) contained in the API Losar
High Blood Pressure Increasing Worldwide drugs.com
January 11, 2017
As the number of people around the world with elevated or high blood pressure increases, so do the number of deaths linked to this "silent killer," a new study contends.

Previous page 1 2 3 Next page